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AbstrACt
Objectives To investigate if centre-specific levels of 
perinatal interventional activity were associated with 
neonatal and neurodevelopmental outcome at 2 years of 
age in two separately analysed cohorts of infants: cohort 
A born at 22–25 and cohort B born at 26–27 gestational 
weeks, respectively.
Design Geographically defined, retrospective cohort study.
setting All nine level III perinatal centres (neonatal 
intensive care units and affiliated obstetrical services) in 
Switzerland.
Patients All live-born infants in Switzerland in 2006–2013 
below 28 gestational weeks, excluding infants with major 
congenital malformation.
Outcome measures Outcomes at 2 years corrected 
for prematurity were mortality, survival with any major 
neonatal morbidity and with severe-to-moderate 
neurodevelopmental impairment (NDI).
results Cohort A associated birth in a centre with high 
perinatal activity with low mortality adjusted OR (aOR 0.22; 
95% CI 0.16 to 0.32), while no association was observed 
with survival with major morbidity (aOR 0.74; 95% CI 0.46 
to 1.19) and with NDI (aOR 0.97; 95% CI 0.46 to 2.02). 
Median age at death (8 vs 4 days) and length of stay 
(100 vs 73 days) were higher in high than in low activity 
centres. The results for cohort B mirrored those for cohort 
A.
Conclusions Centres with high perinatal activity in 
Switzerland have a significantly lower risk for mortality 
while having comparable outcomes among survivors. 
This confirms the results of other studies but in a 
geographically defined area applying a more restrictive 
approach to initiation of perinatal intensive care than 
previous studies. The study adds that infants up to 28 
weeks benefited from a higher perinatal activity and why 
further research is required to better estimate the added 
burden on children who ultimately do not survive.
IntrODuCtIOn  
Over recent decades, progress in perinatal 
care has led to vastly improved survival rates 
for infants born at extremely low gestational 
age (GA). Consequently, the GA limit for 
initiating life-sustaining intensive care at birth 
was lowered to 22 weeks, below which treat-
ment is generally not recommended.1 This, 
however, raised ethical concerns regarding 
the added burden to infants who ultimately 
do not survive and the increased risk of 
neurosensory impairment among those that 
do survive.2 There is little consensus about 
the policy of treating these infants. Instead, 
hospital practices regarding the initiation of 
intensive care have dramatically influenced 
strengths and limitations of this study
 ► Geographically defined cohort study comparing 
2-year outcome of extremely preterm infants be-
tween hospitals with high and low perinatal inter-
ventional activity based on a quantitative score of 3 
obstetric and 4 neonatal indicators.
 ► Crude and risk-adjusted ORs for outcome between 
high and low activity centres were calculated using 
regression models and measuring predictive validity 
of risk adjustment.
 ► Missing outcome data of surviving infants lost to fol-
low-up were addressed by multiple imputation and 
the validity of data imputation was tested by sensi-
tivity analysis using non-imputed data.
 ► The inter-relatedness of some of the perinatal activ-
ity score components (eg, surfactant and respiratory 
support) form a limitation. However, our aim was to 
quantify activity and not measure quality of care. As 
such, the components quantify at best the level of 
proactive care by focusing on the whole repertoire 
of first perinatal supportive interventions.
 ► Further minor limitations are represented by the 
composite nature of the outcome measures ‘any 
major morbidity’ and ‘neurodevelopmental impair-
ment’, which could have led to a loss of information.
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rates of survival and survival without impairment.3 This 
has led to large outcome variation among hospitals. In 
2015, Rysavy et al quantified the effect of perinatal inter-
ventional activity on outcome between a group of 24 
centres of the Eunice Kennedy Shriver National Institute 
of Child Health and Human  Development (NICHD) 
network in the USA. Among infants born at 22–23 weeks 
gestation, centre rates of active treatment accounted for 
78% of the variation in survival between centres. For those 
born at 24 weeks gestation, it accounted for 22% of the 
variation.4 There is a similar variation in decision-making 
approaches in Europe, which appears to reflect local 
philosophy and practice rather than economic or demo-
graphic markers, individual variations in health expendi-
ture or rates of preterm birth.5 
Swiss obstetricians and neonatologists are known to 
be generally restrictive with regard to initiation of inten-
sive care for infants at the limit of viability. A recent 
study revealed that the decision-making regarding initi-
ation of treatment was based almost exclusively on GA 
and that most infants born <24 weeks gestation received 
a priori comfort care.6 Nevertheless, centre-to-centre 
outcome variability has repeatedly been reported 
and is assumed to be in part associated with the local 
ethical decision-making.7–9 What remained unclear was 
whether the lower mortality in some centres leads to 
higher risk of neurodevelopmental impairment (NDI) 
in survivors.
This study aimed to quantify the outcome differ-
ences between centres with a higher propensity towards 
providing active perinatal care at birth from those that 
provide more a priori comfort care. We assessed infants 
in cohort A (22+0 to 25+6 weeks GA) and compared their 
outcome variability with that in cohort B (26+0 to 27+6 
weeks GA) where we expected no difference in either 
perinatal care provision or outcome based on previous 
studies.4 10–13
MethODs
study population and procedure
Geographically defined, retrospective cohort study 
including all live-born infants between 22+0 and 27+6 
weeks of gestation in Switzerland from 2006 to 2013. We 
excluded infants born with a major congenital malfor-
mation, defined as being the primary cause of death 
or requiring surgery or a chromosomal anomaly. We 
also excluded four infants born and treated exclusively 
in three step-down units. We extracted electronically 
recorded data (challenged for plausibility and complete-
ness) from the prospective national database of the Swiss 
Neonatal Network & Follow-up Group (SNN). Data from 
delivery room deaths were audited by a researcher visiting 
the hospitals’ maternity wards.
Participating centres were obliged to inform parents 
about the scientific use of anonymised data.
neonatal data
Perinatal and neonatal variables were defined as follows: 
GA as the best estimate available based on prenatal ultra-
sound examination during the first trimester of preg-
nancy. Birthweight z-scores, intraventricular haemorrhage 
grade 3 or higher (IVH), cystic periventricular leukoma-
lacia (cPVL), bronchopulmonary dysplasia (BPD), severe 
retinopathy of prematurity stages 3–4 (ROP), necrotising 
enterocolitis (NEC), late-onset neonatal sepsis (LOS) and 
socioeconomic status (SES) were defined as previously 
published.14
neurodevelopmental outcome at 2 years of age
Experienced neurodevelopmental or developmental 
paediatricians performed the standardised Swiss follow-up 
assessment15 at 18–24 months corrected age in one of the 
Swiss follow-up centres. Between 2006 and 2012, examina-
tions were based on Bayley Scales of Infant Development, 
2 edition (BSID-II)16 and afterwards on Bayley Scales of 
Infant and Toddler Development, 3 edition (Bayley-III).17 
Up until 2006, some of the children were tested using the 
Griffiths Mental Development Scales-Revised (GMDS)18 
during the transition period to BSID-II. According to 
recent literature,19–22 Bayley-III scores below 85 (-1SD) 
were considered as equivalent of indices below 70 (-2SD) 
in the BSID-II and the GMDS. The GMDS development 
quotient was considered equivalent to BSID-II Mental 
Developmental Index.23 Infants with significant disability 
precluding completion of the development test were 
assigned a development score of 1 below −3SD. Cerebral 
palsy was defined according to Rosenbaum et al24 and was 
graded according to the Gross Motor Function Classifica-
tion System (GMFCS) for children aged ≤2 years.25 Vision 
and hearing were assessed by either direct examination 
or caregiver report.
Perinatal interventional activity score
In order to differentiate between Swiss centres with a 
higher propensity to initiate intensive care for infants 
born below 26 weeks gestation, we calculated a perinatal 
activity score per centre based on the model presented 
by Serenius et al.10 Obstetric and neonatal activity scores 
reflecting the intensity of care in each centre were calcu-
lated on the basis of the rates of three key obstetric 
indicators (delivery at level III hospitals, that is, inborn; 
complete course of antenatal steroids; caesarean section), 
and four key neonatal indicators (surfactant within 
2 hours after birth; any of the following activities in the 
delivery room: bag/mask ventilation, continuous positive 
airway pressure, endotracheal intubation, epinephrine or 
epinephrine supply, cardiac compression; no recorded 
decision for primary non-intervention in the delivery 
room (available for all infants); infants admitted for inten-
sive care (out of infants alive at 30 min after birth)). The 
mean obstetric and neonatal activity scores comprised 
the perinatal activity score (henceforth, activity score). 
Each step included normalisation by assigning the centre 
with the highest rate for each indicator a score of 100; 
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the remaining centres were assigned proportional scores. 
We calculated an activity score for infants born between 
22–25 weeks gestation (cohort A) and a separate one for 
infants born 26–27 weeks gestation (cohort B). The first 
score was used to classify the nine Swiss perinatal centres 
into a ‘low’ and a ‘high’ activity group using the arbitrary 
threshold of an activity score of 80 in order to generate 
two groups of similar size with clear difference in peri-
natal activity. To allow comparison between cohort A and 
cohort B, cohort B was split into the same centres with low 
and high activity as for cohort A. To confirm the dichot-
omous association of perinatal activity with outcome, we 
also tested for a linear association. For this, we generated 
a variable that increases by one for every 5-point increase 
in perinatal activity using the two perinatal activity scores 
for cohort A and B.
Outcome
Outcome parameters were defined as follows: mortality 
at 2 years corrected age, death or moderate-to-severe 
NDI, death or major morbidity, survival with moder-
ate-to-severe NDI and survival with major morbidity. 
Moderate-to-severe NDI was defined as either mental 
or motor development index below 70 (-2SD) in the 
BSID-II; cognitive or motor composite score below 85 
(see below) in the Bayley-III; a global score of the GMDS 
below 70 (-2SD); cerebral palsy with GMFCS above 1; 
the absence of useful hearing even with aids (ie, >90 dB 
hearing level); blindness or only perception of light. 
Major morbidities encompassed IVH, cPVL, BPD, ROP, 
NEC or LOS.
Data completeness
Patient population coverage was assessed by comparison 
with the birth registry of the Swiss Federal Statistical Office 
and yielded 86.4% of all live births between 22 and 27 weeks 
gestation. 1.2% of the datasets were missing information 
on ‘major morbidity’ and were therefore eliminated in 
the non-imputed analyses including this outcome. Other 
data were missing in less than 0.1% of cases. As 2-year 
follow-up data were missing in 11% of all surviving infants 
between 22 and 25 weeks gestation and 17% between 
of 26 and 27 weeks gestation, we performed a fivefold 
imputation with chained equations for the cohorts A (all 
infants), A (survivors), B (all infants) and B (survivors), 
respectively, allowing the calculation of pooled adjusted 
ORs (aORs) for the above-listed outcomes.26 Data for 
imputation were determined as missing at random. As 
a sensitivity analysis, we performed the same tests with 
crude, that is, non-imputed data. As outborn infants were 
by concept unevenly distributed between high and low 
activity centres, they cannot be assumed to be missing at 
random for the imputation. We, therefore, performed 
another sensitivity analysis excluding all outborn infants 
for both the activity score as well as for the regression 
analysis.
statistical analysis
We performed multivariable-adjusted logistic regres-
sion to compare outcome between centres with lower 
and higher perinatal activity. Adjustment was made for 
GA and GA2 (as the combination better models the 
non-linear dependency of most neonatal outcomes 
on GA and therefore results in risk adjustment with 
higher predictive validity), birthweight z-score, male sex, 
multiple births and SES. To estimate the validity of the 
adjustment, we calculated how well the above listed vari-
ables predicted outcome. If this predicted validity is low, 
the adjustment made has limited explanatory power.27 We 
calculated the area under receiver operating characteris-
tics curve (AUC). AUC values between 0.7 and 0.8 were 
considered to represent moderate, and >0.8 to represent 
high predictive validity, respectively. All statistical analyses 
were performed using R V.3.4.28
results
study population and neonatal data
A total of 2063 infants were born alive in Switzer-
land between 2006 and 2013 below 28 weeks gestation 
(figure 1). A total of 1839 of those infants were registered 
by SNN between 2007 and 2013. They correspond to 
1900 life births registered at the Swiss Federal Statistical 
Office in the same time period which results in a popu-
lation coverage of 97% for the study period (reference 
data for 2006 were not available as GA was not included in 
the national register prior to 2007). Of the 2063 infants, 
we excluded four infants because they were born in and 
treated at three step-down units and 85 infants because 
of major congenital malformations. Among the 1974 
included infants, 712 (36%) died before discharge and 
6 (0.3%) after discharge but before reaching 2 years of 
age. In cohorts A and B, 319 (89% of survivors) and 743 
(83%) were assessed at 2 years corrected age, respec-
tively. One hundred ninety-four (15%) children were 
lost to follow-up (109 refused follow-up, 57 could not be 
reached/moved away, 28 unknown loss to follow-up). In 
Figure 1 Study population overview. GA, gestational age; 
NICU, neonatal intensive care unit.
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both cohorts, difference between baseline characteristics 
of children with and without follow-up was negligible 
(table 1), particularly concerning the factor ‘activity score’ 
which determines the comparison groups for the subse-
quent analysis. Outborn children were less frequently 
assessed in both cohorts.
Perinatal interventional activity score
Table 2 displays the proportion of infants receiving either 
of the treatments determining the obstetrical activity 
(items1–3) and the neonatal activity (items4–7) for cohort 
A in each centre. Activity scores were determined out of 
the mean of the obstetric and neonatal activity scores and 
ranged from 57 to 98. Four centres with an activity score <80 
were classified as ‘low activity centres’ encompassing 461 
infants in cohort A and 554 in cohort B. The remaining 
five centres were classified as ‘high activity centres’ and 
combined 466 infants in cohort A and 493 in cohort B. 
A separate centre-specific activity score was determined 
for cohort B using the same routine (online supplemen-
tary table 1). Each 5-point increase in perinatal activity 
score reduced the risk for mortality within 2 years of life 
for cohort A (aOR 0.74, 95% CI 0.68 to 0.80) and cohort 
B (aOR 0.82, 95% CI 0.70 to 0.97).
After risk adjustment, the aOR in cohort A for mortality 
(0.22, 95% CI 0.15 to 0.31) and death or NDI (0.30, 
95% CI 0.21 to 0.42) were significantly lower (figure 2) 
for high compared with low activity centres. After 
restricting the cohort to survivors, aOR for any major 
neonatal morbidities was 0.75 (95% CI 0.47 to 1.19) and 
for moderate-to-severe NDI 0.95 (95% CI 0.46 to 1.98). 
The crude baseline characteristics of low versus high 
activity centres in cohort A (table 3) were comparable 
Table 1 Baseline characteristics cohorts A/B: children with and without 2-year follow-up (FU)
Cohort A (22–25 weeks GA) Cohort B (26–27 weeks GA)
With FU Lost to FU With FU Lost to FU
N 319 (88.6%) 41 (11.4%) 743 (82.9%) 153 (17.1%)
GA (IQR) 25.3 (24.7–25.6) 25 (24.6–25.6) 27 (26.4–27.4)  27 (26.6–27.4)
BW z-score (IQR) −0.1 (−0.6 to 0.4) −0.3 (−0.6 to 0.3) 0 (−0.7 to 0.5)  0.2 (−0.5 to 0.5)
Male sex 53.9% 48.8% 52.9%  56.2%
Multiple births 22.3% 26.8% 26.8%  24.8%
Outborn 2.2% 9.8% 4.2%   7.2%
SES (IQR) 6 (5 to 8) 7 (4.2 to 10) 6 (4 to 8)   6 (4 to 8)
Activity score (IQR) 87.5 (73.7–89.2) 84.1 (77.8–89.2) 85.8 (84.2–91)  88.7 (84.2–91)
Major morbidity 60.8% 53.7% 39.9%  35%
SES, socioeconomic status was calculated by means of a score reflecting both maternal education and paternal occupation, with a maximum 
and minimum scores of 12 and 2, indicating lower and higher status, respectively.
BW, birth weight; GA, gestational age.
Table 2 Centre activity grouping cohort A (standardised ratios)
C 1 C 2 C 3 C 4 C 5 C 6 C 7 C 8 C 9
Highest
proportion*
Inborn (1) 95 98 94 96 96 99 100 96 97 100%
Full course antenatal steroids (2) 56 64 80 88 91 81 100 88 97 51.5%
Caesarean section (3) 44 81 67 50 88 100 93 97 93 60.7%
Obstetric activity 66 83 82 80 94 96 100 96 98 – 
Delivery room intubation or CPAP (4) 37 40 61 83 76 83 83 93 100 71.9%
Surfactant <2 hours (5) 44 39 51 35 73 82 84 97 100 65.6%
Intensive care started (6) 57 78 78 100 79 83 81 88 99 81.7%
Admitted (7) 57 64 77 92 79 79 76 88 100 81.2%
Neonatal activity 49 55 67 78 77 82 81 92 100 –
Activity score 57 68 74 78 84 88 89 93 98 – 
Activity group Low Low Low Low High High High High High – 
(1)–3): key obstetric indicators; (4)–(7): key neonatal indicators; C1–C9: centres 1–9.
*Highest proportion: actual proportion of infants receiving intervention in centre with highest incidence, standardised as 100 in activity score.
CPAP, continuous pulmonary airway pressure.
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for size, GA range, birthweight z-score, multiple births 
and SES. However, high activity centres had more male 
infants and less outborn infants. The crude outcome 
proportions reflect the aOR results. Repeating the same 
evaluation using non-imputed data resulted in almost the 
same point estimates and CIs (dotted lines in figure 2). 
As outborn infants were unevenly distributed between 
children with and without follow-up, we repeated the 
analysis excluding all 75 outborn infants from the begin-
ning for both the activity score and the regression anal-
ysis. The resulting aOR was almost equivalent to the 
ones reported above (online supplementary figure 1). 
Excluding the delivery room deaths, median neonatal 
intensive care unit (NICU) age at death in high activity 
centres was higher (8 vs 4 days) as was length of stay 
(100 vs 73 days). As can be seen in figure 3, the distri-
bution of age at death was different between high and 
low activity centres. In high activity centres, the highest 
density was reached above the median, whereas it was 
below the median in low activity centres. The violin plot 
thereby allows taking the full distribution of the data 
into account rather than relying on median and IQR 
alone.
Centres classified as having ‘high activity’ for cohort 
A, still had a higher perinatal activity score (91 vs 84) 
in cohort B with matching outcome variability. aOR for 
mortality (0.49, 95% CI 0.34 to 0.71) and death or NDI 
(0.72, 95% CI 0.53 to 0.97) were significantly lower in 
high activity centres (figure 2). In contrast to cohort A, 
the aOR for any major morbidities was also significantly 
lower (0.63, 95% CI 0.48 to 0.84) whereas moderate-to-se-
vere NDI outcome in survivors was higher without 
reaching significance (1.17, 95% CI 0.77 to 1.78). Again, 
crude baseline characteristics (table 3) were comparable 
with more male and fewer outborn infants in high activity 
centres. Crude outcomes mirror the aOR result. In cohort 
B, median age at death in NICU in high activity centres 
was again higher (11 vs 6 days), whereas length of stay was 
only somewhat longer (85 vs 78 days).
Figure 2 ORs of outcome when born in a unit with high perinatal interventional activity. ORs with 95% CI of outcome when 
born in high activity units, crude or adjusted for GA, GA2, birthweight z-score, male sex, multiple births and socioeconomic 
status. Dotted lines represent results received when using non-imputed data. AUC, area under receiver operator characteristic 
curve representing predictive validity of risk adjustment. GA, gestational age; NDI, neurodevelopmental impairment.
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Table 3 Low versus high activity centres cohorts A and B
Cohort A (22–25 weeks GA) Cohort B (26–27 weeks GA)
Low activity High activity Low activity High activity
N 461 (49.7%) 466 (50.3%) 554 (52.9%) 493 (47.1%)
GA
(IQR)
24.7 (24–25.3) 24.6 (23.6–25.3) 26.9 (26.4–27.4) 27 (26.4–27.4)
BW z-score
(IQR)
−0.3 (−0.8 to 0.3) −0.4 (−1 to 0.2) 0 (−0.7 to 0.5) 0 (−0.8 to 0.5)
Male sex 51.6% 57.6% 52.1% 55.8%
Multiple births 28.2% 27.5% 24.2% 28.2%
Outborn 3.9% 2.1% 5.2% 3.4%
SES (IQR) 6 (4–8) 6 (5–8) 6 (4–8) 6 (4–8)
Activity score
(IQR)
68.1 (68.1–73.7) 89.2 (87.5–92.7) 84.2 (83.3–85.8) 91 (90.2–92.3)
Mortality 71.4% 51.1% 18.2% 10.1%
  Died in delivery room 41.9% 34.1% 1.6% 1.8%
  NICU mortality 29.5%   17% 16.6% 8.3%
Death or NDI 78.2% 62.9% 30.3% 24.6%
Any major morbidity (survivors) 62.1% 58.7% 43.8% 34.2%
Moderate-to-severe NDI (survivors) 18.3% 18.6% 11.9% 14.3%
Age at death in NICU (days) (IQR) 4 (1.5–10.2) 8 (1.5–18) 6 (3–14) 13 (4–24)
Length of stay (days) (IQR) 73.5 (4–101.8) 100 (63–120) 79 (64–95) 85 (72–97)
SES, socioeconomic status was calculated by means of a score reflecting both maternal education and paternal occupation, with a maximum 
and minimum scores of 12 and 2, indicating lower and higher status, respectively.
BW, birth weight; GA, gestational age; NDI, neurodevelopmental impairment; NICU, neonatal intensive care unit.
Figure 3 Age at death in NICU (days).  Log-transformed age at death in NICU (days) for low and high activity centres in cohort 
A and cohort B. Crude y-axis scale on right-hand side. Violin plot: box-plot with median, IQR and density (width=frequency). 
GA, gestational age; NICU, neonatal intensive care unit.
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neurodevelopmental outcome at 2 years of age
Follow-up assessment was performed at a mean (SD) 
corrected age of 22.6 (3.1) months (table 4). Of 1062 
examined children, 729 (69%), 265 (25%) and 46 (4%) 
were assessed with the Bayley-II, Bayley-III and GMDS, 
respectively, while in 19 (2%) children only a part of a 
developmental assessment could be performed because 
of severe cerebral palsy or poor compliance. A total of 220 
(21%) infants suffered from moderate-to-severe NDI and 
842 (79%) infants showed favourable outcome.
DIsCussIOn
Swiss perinatal centres with a higher score of perinatal 
activity for infants at the borderline of viability (cohort 
A) had significantly lower aOR for mortality and for the 
composite outcome death or NDI. After restricting the 
cohort to survivors at 2 years of age corrected for prema-
turity, there was no significant difference between centres 
with high and low intensity regarding risk for major 
morbidity or NDI. Cohort B mirrored the outcome differ-
ences between high and low activity perinatal centres 
determined for cohort A, that is, significantly lower 
aOR for mortality and for death or NDI. In contrast to 
cohort A, the lower mortality in high activity centres in 
cohort B was based exclusively on NICU mortality. High 
activity centres in cohort B had a significantly lower aOR 
for any major neonatal morbidity. Except for the aOR 
for mortality, death or NDI or any major morbidity in 
cohort A, the predictive validity measured by AUC was 
low to negligible. For those aORs, we would expect the 
true value to lie between the crude and the adjusted level, 
which confirm the results.29
The association between perinatal interventional 
activity and outcome has been reported before. We based 
our centre-specific activity score on the model of the 
Swedish regional activity score published by Serenius et 
al.10 In their study, live-born infants between 22 and 24 
weeks GA treated in regions with high versus low activity 
also had lower aOR for mortality (0.43, 95% CI 0.26 to 
0.73) and for death or NDI (aOR 0.48, 95% CI 0.27 to 
0.84) at 2.5 years corrected age. As in our study, survi-
vors in high activity regions did not have a higher risk for 
any NDI (aOR 0.63, 95% CI 0.31 to 1.28). This reflects 
the difficulty in assessing outcome at 2 years in general 
and using NDI as a measure of efficacy.30 31 Other reports 
between intensity of care and survival date back as far as 
2004 when Håkansson et al for the first time reported how 
a proactive perinatal strategy increases the number of 
Table 4 Outcome at 2 years of age (corrected)
Cohort A Cohort B All infants
Survivors at 2-year follow-up (N) 319 743 1062
Mean age at 2-year follow-up (SD)  22.5 (3) 22.6 (3.1) 22.6 (3.1)
Outcome at 2-year follow-up
  Favourable ND  81.5% 86.9% 85.3%
  Moderate-to-severe NDI  18.5% 13.1% 14.7%
No developmental test performed   2.8% 1.4% 1.8%
BSID-II  63% 71.4% 68.8%
  Mean MDI (SD)  87.3 (18.8) 89.9 (17.2) 89.2 (17.7)
  Mean-PDI (SD)  85.1 (18.7) 88.1 (17.2) 87.3 (17.7)
GMDS   6.0% 3.6% 4.3%
  Mean GMDS w/o motor (SD)  84.2 (18.2) 83.7 (20.7) 83.9 (19.5)
Bayley-III  28.2% 23.6% 25.0%
  Mean cognitive composite score (SD)  98.2 (16.3) 101.4 (13.8) 100.3 (14.7)
  Mean composite motor score (SD)  94.7 (15.2) 97 (13.4) 96.2 (14.0)
Cerebral palsy   7.5% 6.1% 6.5%
  GMFCS 1   5.0% 4.2% 4.4%
  GMFCS 2   1.3% 0.8% 0.9%
  GMFCS 3–5   0.6% 1.1% 0.9%
Severe visual problems   0.0% 0.3% 0.2%
Severe hearing problems   1.7% 0.7%   1%
Cohort B: 26 0/7 to 27 6/7 weeks gestation; Cohort A: 22 0/7 to 25 6/7 weeks gestation.  
BSID-II, Bayley Scales of Infant Development, second edition; BSID-III/B-III, Bayley Scales of Infant and Toddler Development, 
third edition; Favourable ND, favourable neurodevelopment, that is, absence of any NDI;  GMDS, Griffiths Mental Developmental Scales; 
GMFCS, Gross Motor Function Classification System; MDI, Mental Developmental Index; NDI, neurodevelopmental impairment; PDI, 
Psychomotor Developmental Index. 
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live births and improves the infant’s postnatal condition 
in Sweden.32 Rysavy et al were also able to show a clear 
association between the outcome of infants receiving 
active care and those that did not for infants between 
22 and 24 weeks GA, but not for those between 25 and 26 
weeks GA.4 A study determining the perinatal outcome 
for extremely preterm infants in relation to place of birth 
in England reported lower odds for mortality when they 
were born in a level 3 centre with higher perinatal activity 
based on staffing and activity data collected by question-
naire.11 In 2013, an NICHD study could show that ‘centre 
intervention rates’ significantly predicted mortality rates 
for infants <25 weeks but not for infants ≥25 weeks gesta-
tion.12 Centre intervention rates included parameters 
similar or identical to the ones chosen for the calcula-
tion of the activity score in this study. Using yet another 
version of a similar intervention score, the MOSAIC study 
of 2009 (Models of OrganiSing Access to Intensive Care 
for very preterm births) was able to show an association 
between the score and mortality for infants <26 weeks but 
not for infants at 26–27 weeks gestation.13 Swiss centres 
rarely initiated intensive care below 24 weeks gestation 
during the study period.6 8 This is why we chose the same 
GA ranges for cohorts A and B as the MOSAIC study but 
not as the other studies. Yet, even with the more restric-
tive approach, we confirm the results of previous studies 
in infants <26 weeks gestation.
Swiss centres classified as having ‘high activity’ for 
cohort A still had a higher perinatal activity score in 
cohort B. In contrast to the studies reported above,4 10–13 
the resulting outcome variability in cohort B is congruent 
to the variability in cohort A. As variability in mortality 
in cohort B was exclusively observed in NICU but not 
in delivery room-mortality, it is difficult to determine an 
association to either higher perinatal activity or quality 
of care, or a combination of both. Arguments exist for 
each: centres of the high activity group also have a higher 
perinatal activity score in cohort B and the continuous 
perinatal activity score reduces risk of mortality per each 
5-point increase in activity score. As variability in mortality 
in cohort B exists exclusively for NICU and not for delivery 
room mortality, variability in the decision-making process 
regarding redirection of care based on futility may exist. 
On the other hand, centres with a high perinatal activity 
also had a significantly lower aOR for any major morbid-
ities which would favour the assumption of difference in 
quality of care. This would be in line with the observations 
by Smith et al whose findings suggest that the approach 
taken with infants at the limits of viability is associated 
with improved outcomes of more-mature infants.33
As reported in other studies,10 34 median age at death 
was higher in high activity centres. Serenius et al argue 
that the longer duration of life allows for a trial of life, 
whereas Costeloe et al see the reason in different principle 
causes of death with a tendency towards later complica-
tions of prematurity in the case of the group of infants 
dying later.10 34 Figure 3 displays that the age at death for 
both cohorts are comparable in their IQR but, together 
with the longer median length of stay for all infants, indi-
cate an added burden to infants who ultimately do not 
survive in high activity centres.
COnClusIOns
A 5-point increase in perinatal interventional activity 
significantly decreases the aOR for mortality of infants 
born 22–25 weeks gestation in Switzerland. High activity 
centres have a significantly lower aOR for mortality and 
death or NDI and outcome among survivors at 2 years 
of age is comparable. The effect observed was repeated 
for infants between 26 and 27 weeks gestation, indicating 
that all extremely preterm infants benefited. Age at death 
and duration of hospitalisation are higher suggesting a 
higher burden for patients who ultimately do not survive 
in high activity centres. Although the results favour the 
high activity approach, further research is required to 
better estimate the accompanying added burden on the 
children. Outcome data at 5 years of age or later are 
urgently required to confirm these findings with a more 
predictive long-term assessment.
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